Answers are grounded in this paper and cite their sources.
Systematic review characterizes treatment-related adverse events in clinical trials of oncolytic virus therapies for primary CNS tumors, highlighting safety concerns.
To characterize the types, frequencies, grades, and severities of treatment-related adverse events reported in clinical trials of oncolytic virus therapies for primary CNS tumors.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: